10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
56.09
-2.06 (-3.54%)
At close: Aug 14, 2026, 4:00 PM EDT
56.43
+0.34 (0.61%)
Pre-market: Aug 17, 2026, 8:17 AM EDT
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $7.31 billion as of August 17, 2026. Its market cap has increased by 332.60% in one year.
Market Cap
7.31B
Enterprise Value
6.83B
1-Year Change
332.60%
Ranking
Category
Stock Price
$56.09
ChartMarket Cap Chart
Since September 12, 2019, 10x Genomics's market cap has increased from $4.95B to $7.31B, an increase of 47.62%. That is a compound annual growth rate of 5.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 7.31B | 254.06% |
| Dec 31, 2025 | 2.06B | 18.74% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veeva Systems | 39.60B |
| BrightSpring Health Services | 12.86B |
| Tempus AI | 9.40B |
| HealthEquity | 8.76B |
| Hinge Health | 7.14B |
| Waystar Holding | 4.75B |
| Doximity | 4.42B |
| HeartFlow | 3.66B |